CELU
Celularity Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.68
−8.20%Margins
Gross margin
76.0%
EBITDA margin
-292.4%
EBIT margin
-230.9%
Net margin
-345.4%
FCF margin
-49.9%
241.0%
Return on equity
-85.5%
Return on assets
-2159.5%
Return on invested capital
0.24x
Asset turnover
-$13.3M
Cash from operations
$0.21
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025